Home › Funds › Citigroup Inc › ELEV
Citigroup Inc position in ELEV
ELEVATION ONCOLOGY INC
Latest position (Q2 2025)13.44K sh
Reported value held$4.93K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 18.35K | $12.16K | New |
| Q1 2024 | 119.51K | $613.08K | New |
| Q2 2024 | 11.49K | $31.03K | Reduce |
| Q3 2024 | 39.69K | $23.81K | Add |
| Q4 2024 | 44.73K | $25.17K | Add |
| Q1 2025 | 79.97K | $20.72K | Add |
| Q2 2025 | 13.44K | $4.93K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.